Explore how biomarkers can predict BCG failure in high-risk bladder cancer, aiding in personalized treatment strategies.
The FDA has approved atezolizumab combined with chemotherapy for treating stage III dMMR colon cancer, enhancing post-surgery treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results